Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Acquity Group Prices IPO Of 5.5 Mln ADS At $6/ADS - Quick Facts

4/27/2012 1:25 AM ET

Acquity Group Limited (AQ: Quote) announced the pricing of its initial public offering of 5.55 million American depositary shares or "ADS" at a price to the public of $6.00 per ADS. The ADSs are expected to commence trading on the NYSE AMEX on April 27th, 2012 under the symbol "AQ."

The underwriters have an option, exercisable for 30 days from April 26th, 2012, to buy up to an additional 833,333 ADSs from the company at the initial public offering price. Citigroup Inc. and Oppenheimer & Co., Inc. acted as lead underwriters. William Blair & Company and First Analysis Securities Corp. acted as co managers in the offering.

Click here to receive FREE breaking news email alerts for Acquity Group Ltd. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
New home sales in the U.S. unexpectedly showed a substantial decrease in the month of March, according to a report released by the Commerce Department on Wednesday, with sales falling to their lowest level in eight months. The report said new home sales plunged 14.5 percent to an annual rate of 384,000 in March from the revised February rate of 449,000. Euro area's government deficit shrunk last year to match the EU target, while public debt rose and remained above the official ceiling, figures from the Eurostat showed Wednesday. The shrunken government deficits suggest that euro area might be leaving behind the worst troubles of the financial crisis,... Following the strong upward move seen over the past few sessions, stocks may give back some ground in early trading on Wednesday. The major index futures are currently pointing to a modestly lower open for the markets, with the Dow futures down by 6 points.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.